Myosport Relieve Kinesiology

Description

Myosport is a pharmaceutical formulation designed for specific therapeutic applications. It is characterized by its unique composition and intended use in clinical settings. The product is presented in a dosage form that facilitates administration and absorption. Myosport's formulation is optimized for efficacy and safety, ensuring that it meets the rigorous standards required for medical use. Further details regarding its molecular weight, chemical formula, and inactive ingredients are essential for understanding its pharmacological properties and potential interactions.

Uses and Indications

This drug is indicated for the temporary relief of minor aches and pains of muscles and joints associated with various conditions, including Achilles tendonitis, muscle support, back tension, arthritis, sprains, and muscle strain.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

For adults and children over 12 years of age, the recommended application frequency is 2 to 3 times daily to the affected area. Each application should not exceed a duration of 4 days. It is essential to ensure that the application is made to clean, dry skin to optimize the therapeutic effect. Healthcare professionals should monitor the treatment progress and adjust the frequency or duration as necessary based on the patient's response and clinical judgment.

Contraindications

Use is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance or contact with poison control is advised.

Warnings and Precautions

This product is intended for external use only. Healthcare professionals should advise patients to adhere strictly to the provided instructions, ensuring that all directions and warnings on the carton are read and followed meticulously.

When utilizing this product, it is imperative to avoid bandaging tightly and to prevent contact with the eyes and mucous membranes. The application should not occur simultaneously with other topical analgesics, and it is contraindicated for use on wounds or sensitive skin. Patients should be instructed not to remove the product when wet; instead, it should be allowed to dry before being removed slowly.

Patients must be advised to discontinue use and consult a physician if the condition worsens or if symptoms persist for more than 7 days. Additionally, individuals with sensitive skin or a history of cancer should refrain from using this product without prior consultation with a healthcare professional. Pregnant or breastfeeding individuals are also encouraged to seek professional advice before use.

It is crucial to keep this product out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or poison control should be contacted without delay.

Side Effects

Patients using this product should be aware of several important warnings and potential adverse reactions. This product is intended for external use only. It is crucial that patients use the product strictly as directed, adhering to all instructions and warnings provided on the carton. Patients should avoid bandaging the area tightly and should take care to prevent contact with the eyes and mucous membranes. The product should not be used concurrently with other topical analgesics, nor should it be applied to wounds or sensitive skin.

If the condition worsens or if symptoms persist for more than 7 days, patients are advised to stop use and consult a physician. Additionally, individuals with sensitive skin or a history of cancer should discontinue use and seek medical advice. Pregnant or breastfeeding patients should consult a healthcare professional before using this product.

It is also important to keep this product out of reach of children. In the event of accidental ingestion, patients should seek medical assistance or contact poison control immediately.

Drug Interactions

Concurrent use of this medication with other topical analgesics is contraindicated. The combination may increase the risk of adverse effects without providing additional therapeutic benefit. It is advised to avoid using multiple topical analgesics simultaneously to ensure patient safety and optimal therapeutic outcomes. Monitoring for any signs of increased local irritation or systemic effects is recommended if there is a concern about inadvertent overlap in therapy.

Packaging & NDC

Below are the non-prescription pack sizes of Myosport Relieve Kinesiology (menthol). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

The product is indicated for use in pediatric patients aged 12 years and older. For this age group, the recommended application is to the affected area not more than 2 to 3 times daily. Safety and efficacy have not been established in children under 12 years of age. Caution is advised when considering use in this younger population.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any potential adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. The potential risks and benefits must be carefully weighed, as the effects on fetal outcomes and lactation are not fully established. It is essential for women of childbearing potential to seek medical advice to ensure safe use during pregnancy and lactation.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication if they are breastfeeding. There is no specific data available regarding the excretion of this medication in breast milk or its effects on breastfed infants. Therefore, careful consideration and professional guidance are recommended to ensure the safety of both the mother and the nursing infant.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available data regarding dosage adjustments, special monitoring, or safety considerations. Therefore, healthcare professionals should exercise caution when prescribing this medication to patients with reduced kidney function, as the lack of information necessitates careful clinical judgment and monitoring.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, healthcare professionals should be contacted without delay. It is recommended to seek medical assistance or to contact a poison control center promptly to ensure appropriate management and care.

Potential symptoms of overdosage may vary depending on the specific substance involved. Therefore, a thorough assessment by a healthcare professional is essential to determine the appropriate course of action based on the clinical presentation.

Management procedures will typically involve supportive care and symptomatic treatment, tailored to the individual patient's needs. Continuous monitoring and evaluation may be necessary to address any complications that arise from the overdosage.

Nonclinical Toxicology

Consultation with a health professional is advised prior to use during pregnancy or breastfeeding due to potential teratogenic effects. There are no specific non-teratogenic effects or detailed nonclinical toxicology data available. Additionally, no specific information regarding animal pharmacology and toxicology has been provided.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of reach of children. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact poison control immediately. This precaution is crucial to ensure the safety and well-being of children who may inadvertently access the medication.

Storage and Handling

The product is supplied in a resalable container, ensuring ease of use and storage. It is essential to store the product in a cool, dry place to maintain its integrity and effectiveness. Proper storage conditions are crucial for preserving the quality of the product.

Additional Clinical Information

Patients should apply the topical medication to the affected area no more than 2 to 3 times daily, with each application allowed to remain in place for no more than 4 days. Clinicians should advise patients to use the product only as directed, ensuring they read and follow all instructions and warnings on the packaging.

Patients are cautioned against tightly bandaging the area, and they should avoid contact with eyes and mucous membranes. The product should not be used concurrently with other topical analgesics, nor should it be applied to wounds or sensitive skin. Patients should allow the application to dry and remove it slowly; if the condition worsens or symptoms persist beyond 7 days, they should discontinue use and consult a physician. Additionally, individuals with sensitive skin or cancer should stop use and seek medical advice. Pregnant or breastfeeding patients should consult a healthcare professional before use. It is important to keep the product out of reach of children, and in the event of ingestion, medical help or poison control should be contacted immediately.

Drug Information (PDF)

This file contains official product information for Myosport Relieve Kinesiology, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)